Improving Access to Genetic Testing for Neurodevelopmental Disorders
This study looked at how genetic testing is used to diagnose neurodevelopmental disorders (NDDs) in Israel, focusing on children born between 2000 and 2020.
Access research focused on epilepsy in infants, children, and teens, including causes, treatments, developmental impacts, and family support strategies.
This study looked at how genetic testing is used to diagnose neurodevelopmental disorders (NDDs) in Israel, focusing on children born between 2000 and 2020.
This study looked at how cognitive abilities are assessed in children with cerebral palsy (CP).
This study focused on finding better ways to detect focal cortical dysplasia type II (FCD type II) in children, a condition that can cause severe epilepsy that doesn’t respond to medication.
This study looked at a specific gene called DARS2 and its connection to a type of genetic nerve disease known as Charcot-Marie-Tooth (CMT) disease.
This study focused on developing and testing a new automated model called vEpiNetV2, designed to detect interictal epileptiform discharges (IEDs) in patients with epilepsy.
This study looked at the significance of positive spike wave (PSW) discharges in the brains of children aged 1 month to 19 years.
This study looked at epilepsy-dyskinesia syndromes (EDS), which are conditions where people experience both epilepsy and movement disorders.
This study looked at how young people with epilepsy move from pediatric to adult care at a single medical center.
Researchers studied the relationship between genetic risk factors for a type of epilepsy called temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) and brain structure in healthy children.